Source comparison
Best CJC-1295 no DAC & Ipamorelin Dosage: Protocol Comparison
| Protocol Type | CJC-1295 no DAC Dose | Ipamorelin Dose | Frequency | Total Daily Exposure | Optimal Use Case | Professional Assessment ||—|—|—|—|—|—|| Conservative Starter | 100mcg | 100mcg | 2x daily (AM, PM) | 400mcg combined | First-time users, risk-avers
This comparison does not assign a generated winner or score.
- | Protocol Type | CJC-1295 no DAC Dose | Ipamorelin Dose | Frequency | Total Daily Exposure | Optimal Use Case | Professional Assessment ||—|—|—|—|—|—|| Conservative Starter | 100mcg | 100mcg | 2x daily (AM, PM) | 400mcg combined | First-time users, risk-averse protocols, older populations (>50 years) | Lowest effective dose for measurable IGF-1 elevation (15-25% increase). Minimizes side effect risk but produces slower muscle accrual. Expect 0.5-1lb lean mass gain per month. || Standard Research | 100mcg | 100mcg | 3x daily (AM, post-workout, PM) | 600mcg combined | Active individuals with structured resistance training 4-6x weekly | Gold standard for muscle growth research. Produces IGF-1 elevation of 30-50% and lean mass gains of 1.5-2.5lbs per month when combined with progressive overload and adequate protein (1.6-2.2g/kg). || Advanced Performance | 200mcg | 200mcg | 3x daily (AM, post-workout, PM) | 1200mcg combined | Experienced users with confirmed suboptimal response at standar